Patents by Inventor Audrey Baker

Audrey Baker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100254992
    Abstract: The present invention relates to at least one novel anti-MCP-1 antibody having specific epitopes, including isolated nucleic acids that encode at least one anti-MCP-1 antibody, MCP-1, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
    Type: Application
    Filed: June 30, 2008
    Publication date: October 7, 2010
    Inventors: Anuk Das, Raymond Sweet, Ping Tsui, Deidra Bethea, Sheng-Jiun Wu, James Kang, Audrey Baker
  • Patent number: 7365154
    Abstract: The invention concerns antagonists of alphav-containing integrins which have therapeutic activity in oncology applications and methods for selecting such antagonists using a peptide which competes for alphaV-integrin binding with a known monoclonal antibody having demonstrated anti-tumor activity. The claimed peptide represents a conformational epitope or mimotope present on the ligand to which the therapeutic antibodies selectively bind.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: April 29, 2008
    Assignee: Centocor, Inc.
    Inventors: David Shealy, Sam Wu, Yan Chen, Audrey Baker
  • Publication number: 20070212355
    Abstract: Mammalian GLP-2 mimetibodies, polypeptides and nucleic acids are disclosed. Methods of utilizing the mimetibodies and polypeptides to treat GLP-2 related diseases are also disclosed.
    Type: Application
    Filed: October 24, 2006
    Publication date: September 13, 2007
    Inventors: Audrey Baker, Beverly Moore, Thomas Nesspor, Karyn O'Neil, Jeffrey Palmer, Kristen Picha, Sarah Sague
  • Publication number: 20050084491
    Abstract: The invention concerns antagonists of alphav-containing integrins which have therapeutic activity in oncology applications and methods for selecting such antagonists using a peptide which competes for alphaV-integrin binding with a known monoclonal antibody having demonstrated anti-tumor activity. The claimed peptide represents a conformational epitope or mimotope present on the ligand to which the therapeutic antibodies selectively bind.
    Type: Application
    Filed: June 22, 2004
    Publication date: April 21, 2005
    Inventors: David Shealy, Sam Wu, Yan Chen, Audrey Baker